Literature DB >> 6322677

Placental transfer of cefotiam dihydrochloride.

I Miyakawa, H Inoue, T Kuroki, H C Lee, M Azegami, N Mori.   

Abstract

The concentrations of cefotiam dihydrochloride (CTM) in maternal and fetal blood and in amniotic fluid were determined by bioassay in 38 women at parturition. With an intravenous infusion of 1 g of CTM, the decline in concentration of CTM in maternal blood was biphasic; CTM was not detectable at 6 h after administration. Peak levels of CTM in umbilical cord blood (13.0 to 23.9 micrograms/ml) were attained between 15 and 28 min after intravenous infusion; those in amniotic fluid (19.6 to 23.5 micrograms/ml) were attained at ca. 2.5 h.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6322677      PMCID: PMC185457          DOI: 10.1128/AAC.25.1.147

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  6 in total

1.  Placental transfer of disodium sulbenicillin.

Authors:  I Miyakawa; K Taniyama; H Inoue; H C Lee; N Mori
Journal:  Antimicrob Agents Chemother       Date:  1982-05       Impact factor: 5.191

2.  Current concepts of amniotic fluid dynamics.

Authors:  A E Seeds
Journal:  Am J Obstet Gynecol       Date:  1980-11-01       Impact factor: 8.661

3.  Placental transfer of ampicillin.

Authors:  M A MacAulay; M Abou-Sabe; D Charles
Journal:  Am J Obstet Gynecol       Date:  1966-12-01       Impact factor: 8.661

4.  Transfer of ampicillin into fetus and amniotic fluid from maternal plasma in late pregnancy.

Authors:  R E Bray; R W Boe; W L Johnson
Journal:  Am J Obstet Gynecol       Date:  1966-12-01       Impact factor: 8.661

5.  Placental transfer of cefuroxime.

Authors:  I Craft; B M Mullinger; M R Kennedy
Journal:  Br J Obstet Gynaecol       Date:  1981-02

6.  Pharmacokinetics of cefoxitin in patients at term gestation: lavage versus intravenous administration.

Authors:  J F Flaherty; G W Boswell; C A Winkel; J P Elliott
Journal:  Am J Obstet Gynecol       Date:  1983-08-01       Impact factor: 8.661

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.